- Antiemetics, antipyretics, and anxiolytics will be administered as indicated. Interventions: The women will give a full informed consent, after which they will be randomized to receive 400 µg of vaginal or sublingual misoprostol Cytotec® (Searle Pharmaceuticals, Bucks, United Kingdom) after admission to the induction ward. This dose and route of administration will be repeated every 4 hours, if required as long as the patient is undelivered up to 48 hours following initiation of induction.